Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  03/29/2006
 
Trade Name:  Relenza
 
Generic Name or Proper Name (*):  zanamivir
 
Indications Studied:  Prevention of influenza in children 5 years of age and older
 
Label Changes Summary:  Safety and effectiveness for prophylaxis based on 4 clinical studies in patients 5-16 years of age No differences in safety and effectiveness were observed between pediatric and adult subjects. Dosing information provided Studies waived in children <5 years of age New indication
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  GlaxoSmithKline
 
NNPS:  FALSE'
 
Therapeutic Category:  Antiviral
 
-
-